United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 12, 2026 · Filed May 13, 2026

On May 12, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$578.38 for US$5.49M under a trading plan, leaving 40,513 shares. Filed May 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$578.38 average (US$568.83 to US$583.44)
Value
US$5.49M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 12, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 12, 2026Common StockSale240US$568.8349,773Direct
May 12, 2026Common StockSale400US$570.3149,373Direct
May 12, 2026Common StockSale106US$571.7149,267Direct
May 12, 2026Common StockSale293US$573.1248,974Direct
May 12, 2026Common StockSale401US$573.7048,573Direct
May 12, 2026Common StockSale753US$575.4747,820Direct
May 12, 2026Common StockSale767US$576.2347,053Direct
May 12, 2026Common StockSale1,062US$577.4445,991Direct
May 12, 2026Common StockSale778US$578.4645,213Direct
May 12, 2026Common StockSale492US$579.6744,721Direct
May 12, 2026Common StockSale1,706US$580.6243,015Direct
May 12, 2026Common StockSale982US$581.6242,033Direct
May 12, 2026Common StockSale1,464US$582.8040,569Direct
May 12, 2026Common StockSale56US$583.4440,513Direct

Source

View original at SEC

Related